Breast Cancer

These seven breast cancer clinical trials are recruiting patients now, spanning early-stage, HR-positive, HER2-positive and triple-negative disease.

Two sisters discover they share a BRCA2 mutation, but choose different paths to manage their breast cancer risk and navigate life as previvors.

A breast cancer survivor reflects on the complicated meaning of pink, remembering what cancer took, those still fighting and the people behind the ribbon.

Paxalisib, first studied in brain cancer, may help HR+ breast tumors respond to CDK4/6 inhibitors again, based on early lab data.

A cancer survivor shares what to say, what not to say and how listening can help support someone through cancer treatment and beyond.

The investigational drug, first developed for brain cancer, is being tested to see whether it can make resistant tumors respond to treatment again.

FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer after endocrine therapy.

A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.

Twenty-three years after a breast cancer diagnosis at 39, a survivor explains why her garage gym became a place to rebuild strength.

My daughter was 27 when breast cancer forced a decision about her fertility in days, and I keep thinking about the young women who can't afford that choice.

AI is changing breast cancer screening, helping doctors detect cancer and predict future risk. Learn what AI mammography means for patients.

FDA grants accelerated approval to camizestrant for certain advanced breast cancers with ESR1 mutations, offering a new treatment option.

Four breast cancer treatments are awaiting FDA decisions, with two due before the end of 2026. Here's what's under review, what the data show and what it means.

Dr. Jenni Sheng discussed weight management after breast cancer, when medication may be considered and why survivorship care goes beyond cancer surveillance.

The A-NEW study found that 42% of breast cancer survivors with slower early weight loss reached the 5% goal after Contrave was added.

After breast cancer treatment ends, survivorship can bring unexpected challenges. One survivor shares how she learned to heal and redefine who she is.

Dr. Maria Margarete Karsten discusses how weekly symptom monitoring helped identify changes between visits and what patients told her about using it.

I have worked alongside Lori Ranallo for 23 years and watched her guide patients with breast cancer from diagnosis through survivorship and beyond.

Breast oncologist Dr. Zunairah Shah explains how breast cancer research is improving treatment, biomarker testing and options such as antibody-drug conjugates.

Janet Fuller, DNP, RN, OCN, of Vanderbilt University Medical Center, helped two young breast cancer patients form a support group that now guides dozens of women through diagnosis and treatment.

Laura Yeager reflects on attending a Bridgerton-themed gala as a flat-chested breast cancer survivor, finding humor and freedom in a room full of corsets and cleavage.

Weekly smartphone check-ins that alerted the care team when symptoms worsened and improved physical functioning at six months.

After moving two hours away, a survivor weighs staying with the cancer center that knows her history against finding an oncologist close to home.

After breast cancer, one survivor reflects on reclaiming her life by remodeling her kitchen and embracing the freedom to focus on something beyond cancer.

Post-mastectomy bra ads can be emotional. Learn how focusing on your own comfort and needs can help you choose the right undergarment.